ArticleTrials2022

Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).

Armin Attar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.